OPIOID RECEPTOR ANTAGONIST FOR USE IN TREATING PATIENTS WITH SEVERE CONSTIPATION INDUCED BY HIGH OPIATE DOSAGE REGIMEN

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160256453A1
SERIAL NO

14828043

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a pharmaceutical composition comprising an opioid receptor antagonist, or a derivative or a pharmaceutically acceptable salt thereof, as an active substance, wherein the composition releases the active substance in a prolonged manner. The composition that is suitable for an administration period of at least twelve-hours for the treatment of severe opioid-induced constipation in patients receiving a daily dosage of opioid equivalent to at least 80 mg of morphine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEVELCO PHARMA SCHWEIZ AGHOHENRAINSTRASSE 12 PRATTELN 4133

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Golfier, Isabelle Bantzenheim, FR 6 5
Jakob, Silvia Bernau, DE 4 1
Mundszinger, Olaf Efringen-Kirchen, DE 8 20
Rey, Helene Rosenau, FR 12 23
Rusch, Oliver Basel, CH 5 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation